Arison BH - Search Results

1

Characterization of 2'-deoxycytidine adducts derived from 4-oxo-2-nonenal, a novel lipid peroxidation product.

Pollack M, Oe T, Lee SH, Silva Elipe MV, Arison BH, Blair IA. Pollack M, et al. Among authors: arison bh. Chem Res Toxicol. 2003 Jul;16(7):893-900. doi: 10.1021/tx030009p. Chem Res Toxicol. 2003. PMID: 12870892

2

A novel lipid hydroperoxide-derived modification to arginine.

Oe T, Lee SH, Silva Elipe MV, Arison BH, Blair IA. Oe T, et al. Among authors: arison bh. Chem Res Toxicol. 2003 Dec;16(12):1598-605. doi: 10.1021/tx034178l. Chem Res Toxicol. 2003. PMID: 14680374

3

Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins.

Singh R, Silva Elipe MV, Pearson PG, Arison BH, Wong BK, White R, Yu X, Burgey CS, Lin JH, Baillie TA. Singh R, et al. Among authors: arison bh. Chem Res Toxicol. 2003 Feb;16(2):198-207. doi: 10.1021/tx025635l. Chem Res Toxicol. 2003. PMID: 12588191

4

Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation.

Zhang KE, Naue JA, Arison B, Vyas KP. Zhang KE, et al. Chem Res Toxicol. 1996 Mar;9(2):547-54. doi: 10.1021/tx950183g. Chem Res Toxicol. 1996. PMID: 8839061

5

Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol.

Neelamkavil S, Arison B, Birzin E, Feng JJ, Chen KH, Lin A, Cheng FC, Taylor L, Thornton ER, Smith AB 3rd, Hirschmann R. Neelamkavil S, et al. J Med Chem. 2005 Jun 16;48(12):4025-30. doi: 10.1021/jm058184l. J Med Chem. 2005. PMID: 15943475

6

Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.

Singh R, Chen IW, Jin L, Silva MV, Arison BH, Lin JH, Wong BK. Singh R, et al. Among authors: arison bh. Drug Metab Dispos. 2001 Dec;29(12):1578-87. Drug Metab Dispos. 2001. PMID: 11717177

7

Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.

Balani SK, Xu X, Pratha V, Koss MA, Amin RD, Dufresne C, Miller RR, Arison BH, Doss GA, Chiba M, Freeman A, Holland SD, Schwartz JI, Lasseter KC, Gertz BJ, Isenberg JI, Rogers JD, Lin JH, Baillie TA. Balani SK, et al. Among authors: arison bh. Drug Metab Dispos. 1997 Nov;25(11):1282-7. Drug Metab Dispos. 1997. PMID: 9351905 Clinical Trial.

8

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.

Balani SK, Xu X, Arison BH, Silva MV, Gries A, DeLuna FA, Cui D, Kari PH, Ly T, Hop CE, Singh R, Wallace MA, Dean DC, Lin JH, Pearson PG, Baillie TA. Balani SK, et al. Among authors: arison bh. Drug Metab Dispos. 2000 Nov;28(11):1274-8. Drug Metab Dispos. 2000. PMID: 11038152

9

Metabolism of rofecoxib in vitro using human liver subcellular fractions.

Slaughter D, Takenaga N, Lu P, Assang C, Walsh DJ, Arison BH, Cui D, Halpin RA, Geer LA, Vyas KP, Baillie TA. Slaughter D, et al. Among authors: arison bh. Drug Metab Dispos. 2003 Nov;31(11):1398-408. doi: 10.1124/dmd.31.11.1398. Drug Metab Dispos. 2003. PMID: 14570773

10

Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.

Balani SK, Arison BH, Mathai L, Kauffman LR, Miller RR, Stearns RA, Chen IW, Lin JH. Balani SK, et al. Among authors: arison bh. Drug Metab Dispos. 1995 Feb;23(2):266-70. Drug Metab Dispos. 1995. PMID: 7736923 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters